Skip main navigation

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

Surveillance Snapshot: Trends in Pharmacy Prescriptions by Therapeutic Class Among Active Component Members of the U.S. Armed Forces, 2014–2023

Image of 4alternate8102374. The Military Health System's Pharmacy Data Transaction Service includes prescription orders originating from military hospitals and clinics, mail order, and retail-dispensed facilities.

Annual Prescription Prevalence by AHFS Therapeutic Class, Active Component, 2014-2023. This graph comprises 10 lines on the horizontal, or x-, axis that depict the 10 drug therapeutic classes with the highest cumulative period prevalence proportions for each year from 2014 to 2023. The x-, or horizontal, axis presents each year during the 10 year period. The y-, or vertical, axis presents percent prevalence of each drug. Each line connects 10 points that represent the annual prevalence of a specific drug class. Central nervous system agents were, by far, the drug class with the highest prevalence, ranging from a high of nearly 65 percent in 2015 to a low of around 50 percent in 2020, where it has remained ever since. All other drug classes are consistently below 35 percent prevalence, with anti-infective agents consistently the second most prevalent and, at only slightly less prevalence, ear, nose and throat preparations the third most prevalent. All prescriptions declined in prevalence between 2019 and 2020, but have remained steady or gradually increased to former prevalence levels thereafter.   This Surveillance Snapshot presents trends in pharmacy prescriptions ordered from 2014 to 2023 for active component service members of the U.S. Army, Navy, Air Force, Marine Corps, Coast Guard, and Space Force. Pharmacy prescriptions were queried from the Pharmacy Data Transaction Service, which includes prescription orders originating from military hospitals and clinics, mail order, and retail-dispensed facilities. The American Hospital Formulary System1 pharmacologic-therapeutic codes were utilized to identify ACSMs with pharmacy orders under a first-tier class (2-digit therapeutic class codes) each year. The annual prevalence of each therapeutic class was calculated per person using mid-year estimates for all ACSMs. The figure depicts AHFS classes representing the 10 highest cumulative period prevalence proportions.

Throughout the 10-year period, central nervous system agents accounted for the highest prescription prevalence. Of the 658,598 ACSMs with prescriptions for a CNS agent in 2023, the leading three prescription orders for ACSMs further classified under a 6-digit AFHS code included other nonsteroidal anti-inflammatory agents (n=424,968; code 280804), analgesics and antipyretics (n=285,082; code 280892), and tricyclics other norepinephrine-reuptake inhibitors (n=172,790; code 281604). Excluding cardiovascular drugs, the prevalence of ACSMs receiving prescription orders decreased in all 9 other therapeutic classes during the SARS-CoV-2 pandemic. From 2019 to 2021, the largest prevalence declines were observed for respiratory tract agents (17.7% to 8.9%), EENT preparations (32.1% to 22.4%), antihistamine drugs (17.6% to 12.3%), autonomic drugs (25.7% to 18.7%), and anti-infective agents (32.6% to 24.8%). Following the pandemic, the prevalence of ACSMs receiving prescription orders during 2023 increased to a highest point observed over the 10-year surveillance period within 2 therapeutic classes, including respiratory tract agents (19.0%) and skin and mucous membrane agents (23.9%).

Two additional therapeutic classes not depicted in the figure demonstrated substantial prevalence increases during the surveillance period. From 2014 to 2023, the prevalence of ACSMs with orders for serum/toxoid/vaccines (class 8000000) increased from 2.4% to 11.6% and miscellaneous therapeutic agents (class 920000) increased from 8.7% to 14.4%. While PDTS includes prescriptions covered under the TRICARE health benefit, intended to provide primary health care coverage for all ACSMs, it does not document over-the-counter medications. Thus, the results presented in this Surveillance Snapshot may underestimate true prevalence for some therapeutic classes.

Author Affiliations

Epidemiology and Analysis Section, Armed Forces Health Surveillance Division, Defense Health Agency

Reference

  1. American Society of Health System Pharmacists. AFHS Pharmacologic-Therapeutic Classification. 2023. Accessed Jun. 12, 2023. https://ahfsdruginformation.com/ahfs-classification-drug-assignments

You also may be interested in...

Article
Sep 1, 2022

Evaluation of the MSMR Surveillance Case Definition for Incident Cases of Hepatitis C

U.S. Marine Corps Lance Cpl. Angel Alvarado, a combat graphics specialist, donates blood for the Armed Services Blood Program (ASBP).

The validity of military hepatitis C virus (HCV) surveillance data is uncertain due to the potential for misclassification introduced when using administrative databases for surveillance purposes. The objectives of this study were to assess the validity of the surveillance case definition used by the Medical Surveillance Monthly Report (MSMR) for HCV ...

Article
Sep 1, 2022

Brief Report: Menstrual Suppression Among U.S. Female Service Members in the Millennium Cohort Study

U.S. Marine Corps Lance Cpl. Bobby Brodeur, a Gilford, New Hampshire, native and machine gunner with 3rd Battalion, 6th Marine Regiment, 2d Marine Division, conducts gun drills at Camp Lejeune, North Carolina, Oct. 13, 2022. Brodeur is currently serving as a machine gunner with 3/6 and is one of three female infantry Marines in Kilo Co. She has demonstrated an unwavering commitment to 3/6 through her high physical fitness scores and leading by example within the platoon. (U.S. Marine Corps photo by Lance Cpl. Megan Ozaki)

Menstrual suppression allows for the control or complete suppression of menstrual periods through hormonal contraceptive methods. In addition to preventing pregnancy, suppression can alleviate medical conditions and symptoms associated with menstruation such as iron deficiency anemia,1 eliminate logistical hygiene-related challenges, and improve ...

Article
Sep 1, 2022

Update: Routine Screening for Antibodies to Human Immunodeficiency Virus, U.S. Armed Forces, Active and Reserve Components, January 2017–June 2022

NAVAL MEDICAL CENTER CAMP LEJEUNE, North Carolina - As the leading petty officer for Naval Medical Center Camp Lejeune's Community Health Clinic, HM2 Kameron Jacobs is part of the first satellite team to treat service members living with HIV.

This report provides an update through June 2022 of routine screening results for antibodies to the human immunodeficiency virus (HIV) among members of the active and reserve components of the U.S. Armed Forces. During the full 5 and 1/2-year surveillance period, the HIV seropositivity rates for active component service members were 0.21 positives per ...

Article
Aug 1, 2022

Musculoskeletal Injuries During U.S. Air Force Special Warfare Training Assessment and Selection, Fiscal Years 2019–2021.

U.S. Air Force Capt. Hopkins, 351st Special Warfare Training Squadron, Instructor Flight commander and Chief Combat Rescue Officer (CRO) instructor, conducts a military free fall equipment jump from a DHC-4 Caribou aircraft in Coolidge, Arizona, July 17, 2021. Hopkins is recognized as the 2020 USAF Special Warfare Instructor Company Grade Officer of the Year for his outstanding achievement from January 1 to December 31, 2020.

Musculoskeletal (MSK) injuries are costly and the leading cause of medical visits and disability in the U.S. military.1,2 Within training envi­ronments, MSK injuries may lead to a loss of training, deferment to a future class, or voluntary disenrollment from a training pipeline, all of which are impediments to maintaining full levels of manpower and ...

Article
Aug 1, 2022

Brief Report: Pain and Post-Traumatic Stress Disorder Screening Outcomes Among Military Personnel Injured During Combat Deployment.

U.S. Air Force Airman 1st Class Miranda Lugo, right, 18th Operational Medical Readiness Squadron mental health technician and Guardian Wingman trainer, and Maj. Joanna Ho, left, 18th OMRS director of psychological health, discuss the suicide prevention training program, Guardian Wingman, at Kadena Air Base, Japan, Aug. 20, 2021. Guardian Wingman aims to promote wingman culture and early help-seeking behavior. (U.S. Air Force photo by Airman 1st Class Anna Nolte)

The post-9/11 U.S. military conflicts in Iraq and Afghanistan lasted over a decade and yielded the most combat casualties since the Vietnam War. While patient survivability increased to the high­est level in history, a changing epidemiology of combat injuries emerged whereby focus shifted to addressing an array of long-term sequelae, including ...

Article
Jul 1, 2022

Surveillance Trends for SARS-CoV-2 and Other Respiratory Pathogens Among U.S. Military Health System Beneficiaries, 27 September 2020–2 October 2021.

Staff Sgt. Misty Poitra and Senior Airman Chris Cornette, 119th Medical Group, collect throat swabs during voluntary COVID-19 rapid drive-thru testing for members of the community while North Dakota Army National Guard Soldiers gather test-subject data in the parking lot of the FargoDome in Fargo, N.D., May 3, 2020. The guardsmen partnered with the N.D. Department of Health and other civilian agencies in the mass-testing efforts of community volunteers. (U.S. Air National Guard photo by Chief Master Sgt. David H. Lipp)

Respiratory pathogens, such as influenza and adenovirus, have been the main focus of the Department of Defense Global Respiratory Pathogen Surveillance Program (DoDGRPSP) since 1976.1. However, DoDGRPSP also began focusing on SARS-CoV-2 when COVID-19 was declared a pandemic illness in early March 2020.2. Following this declaration, the DOD quickly ...

Article
Jul 1, 2022

Suicide Behavior Among Heterosexual, Lesbian/Gay, and Bisexual Active Component Service Members in the U.S. Armed Forces.

  The DOD’s theme for National Suicide Prevention Month is “Connect to Protect: Support is Within Reach.” Deployments, COVID-19 restrictions, and the upcoming winter season are all stressors and potential causes for depression that could lead to suicidal ideations. Options are available to individuals who are having thoughts of suicide and those around them (Photo by Kirk Frady, Regional Health Command Europe).

Lesbian, gay, and bisexual (LGB) individuals are at a particularly high risk for suicidal behavior in the general population of the United States. This study aims to determine if there are differences in the frequency of lifetime suicide ideation and suicide attempts between heterosexual, lesbian/gay, and bisexual service members in the active ...

Article
Jul 1, 2022

Establishment of SARS-CoV-2 Genomic Surveillance Within the Military Health System During 1 March–31 December 2020.

Dr. Peter Larson loads an Oxford Nanopore MinION sequencer in support of COVID-19 sequencing assay development at the U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland. (Photo by John Braun Jr., USAMRIID.)

This report describes SARS-CoV-2 genomic surveillance conducted by the Department of Defense (DOD) Global Emerging Infections Surveillance Branch and the Next-Generation Sequencing and Bioinformatics Consortium (NGSBC) in response to the COVID-19 pandemic. Samples and sequence data were from SARS-CoV-2 infections occurring among Military Health System ...

Article
Jul 1, 2022

Brief Report: Phase I Results Using the Virtual Pooled Registry Cancer Linkage System (VPR-CLS) for Military Cancer Surveillance.

A patient at Naval Hospital Pensacola prepares to have a low-dose computed tomography test done to screen for lung cancer. Lung cancer is the leading cause of cancer-related deaths among men and women. Early detection can lower the risk of dying from this disease. (U.S. Navy photo by Jason Bortz)

The Armed Forces Health Surveillance Division, as part of its surveillance mission, periodically conducts studies of cancer incidence among U.S. military service members. However, service members are likely lost to follow-up from the Department of Defense cancer registry and Military Health System data sets after leaving service and during periods of ...

Article
Jun 1, 2022

Morbidity Burdens Attributable to Various Illnesses and Injuries, Deployed Active and Reserve Component Service Members, U.S. Armed Forces, 2021

As in previous years, among service members deployed during 2021, injury/poisoning, musculoskeletal diseases and signs/symptoms accounted for more than half of the total health care burden during deployment. Compared to garrison disease burden, deployed service members had relatively higher proportions of encounters for respiratory infections, skin ...

Skip subpage navigation
Refine your search
Last Updated: July 26, 2024
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery